The large global burden of respiratory syncytial virus (RSV) respiratory tract infections in
young children and older adults has gained increased recognition in recent years. Recent …

Respiratory syncytial virus (RSV) stands as the foremost cause of infant hospitalization
globally, ranking second only to malaria in terms of infant mortality. Although three vaccines …

Respiratory syncytial virus (RSV) causes respiratory disease and complications in infants,
the elderly and the immunocompromised. While three vaccines and two prophylactic …

Infections by negative strand RNA viruses (NSVs) induce the formation of viral inclusion
bodies (IBs) in the host cell that segregate viral as well as cellular proteins to enable efficient …

Respiratory Syncytial Virus (RSV) poses a significant global health concern as a major
cause of lower respiratory tract infections (LRTIs). Over the last few years, substantial efforts …

Numerous studies have led to a better understanding of the mechanisms of action of viruses
in systemic infections for the development of prevention strategies and very promising …

Respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) are related RNA
viruses responsible for severe respiratory infections and resulting disease in infants, elderly …

Human respiratory syncytial virus (hRSV) is a major cause of acute lower respiratory tract
infections in children under the age of two as well as in the elderly and …

Epithelial barriers separate the human body from the environment to maintain homeostasis.
Compared to the skin and gastrointestinal tract, the respiratory barrier is the thinnest and …

Ethnopharmacological relevance The plants in the genus Erigeron are known to exhibit
antiviral activities, including those against the respiratory syncytial virus (RSV). In traditional …